CytRx Corporation Share Price Nasdaq
Equities
US2328283013
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 6L 5.37Cr |
---|---|---|---|---|---|
Net income 2022 | -40L -33Cr | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 11.45L 9.56Cr | Net cash position 2023 | 20.36L 17Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.05
x | P/E ratio 2023 |
1.91
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.44% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10/22/10 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01/07/01 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29/21/29 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27/22/27 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12/17/12 |
1st Jan change | Capi. | |
---|---|---|
+33.37% | 4.95TCr | |
+1.55% | 4.26TCr | |
+49.11% | 4.25TCr | |
-4.22% | 2.91TCr | |
+11.57% | 2.66TCr | |
-21.00% | 1.86TCr | |
+7.36% | 1.32TCr | |
+28.30% | 1.25TCr | |
+23.80% | 1.21TCr |